Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
about
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeMolecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli.Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome.All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection.Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS).Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.Molecular analysis of Shiga toxigenic Escherichia coli O111:H- proteins which react with sera from patients with hemolytic-uremic syndromeDecreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin-producing clone of pathogenic Escherichia coli.Human milk secretory antibodies against attaching and effacing Escherichia coli antigensLipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli.Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinibGlycan:glycan interactions: High affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cellsMaternally and naturally acquired antibodies to Shiga toxins in a cohort of calves shedding Shiga-toxigenic Escherichia coliInduction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milkRole for flagella but not intimin in the persistent infection of the gastrointestinal tissues of specific-pathogen-free chicks by shiga toxin-negative Escherichia coli O157:H7.Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization.Land application of treated sewage sludge: quantifying pathogen risks from consumption of crops.A model of the transmission of micro-organisms in a public setting and its correlation to pathogen infection risks.Matrix effects, nonuniform reduction and dispersion in risk assessment for Escherichia coli O157.Escherichia coli O157:H7 as an emerging foodborne pathogen: a literature review
P2860
Q28087714-6FBA103A-CB54-4BCF-A6FC-AC2A161B302AQ30798461-AB3EBF3A-7E0E-4DD2-B4B4-2BA857947558Q33332304-07C5C5EE-75B6-4D06-B4FD-DD286F9EEBA6Q33338331-B413AE76-6798-4D96-8FBB-24F8A3F4A884Q33376138-16E7DB26-BA86-452A-B7B9-808A97E3283BQ33380835-5DCC57C5-5730-4358-AF08-5E769FE0BE85Q33399468-8563A9DF-A89B-4E2C-9E87-9540275CF0CCQ33412642-B8E30750-8DAA-49E8-8928-D2566F3581CBQ33502058-4BF0CAB9-9470-48C8-9231-97A2DC6F6CA6Q34002734-F4146ABD-F892-4B85-B4A4-35DD542CC1CEQ34006082-72F5576D-5726-4546-8F3F-2A4C138A2FA6Q34261800-C4C04EA5-A28F-4B5A-B253-0C10E567BC82Q34275923-763D9635-6765-41E1-B439-0AC03FFB3655Q34289818-02E219E6-9E49-4455-B2F3-B0187EE4401FQ36314226-151E7569-6201-4E4D-99DB-C1751582A889Q36382092-BA3496CF-6A79-4874-9D67-7834611D565FQ36435129-BADC875F-9E99-498C-B647-82C95CC17861Q37204311-673468F0-3970-4710-8302-11F45157433DQ37595508-DF6AA3CF-B6C7-4AEC-866A-DAD530E9D4CCQ40454499-FAF4C953-1882-4DB5-9ECB-266D41A3B738Q42248495-36B5C880-EBDA-42C8-B1A2-552FCDE43CB9Q43318389-E45F4CA6-AC16-47F5-8B68-417CB3799765Q43338894-2815D0C4-DDF8-4217-908A-1361F4B435EBQ54482079-2BD169E0-878C-40B0-8B91-ABB807E2D580Q56765607-679B8513-8944-442B-863A-AE854C8102C6
P2860
Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@ast
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@en
type
label
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@ast
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@en
prefLabel
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@ast
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@en
P2093
P921
P356
P1476
Antibodies to lipopolysacchari ...... epithelial (Henle 407) cells.
@en
P2093
P356
10.1006/MPAT.1997.0172
P577
1998-01-01T00:00:00Z